Clinical relevance of angiogenesis-modulating factors in patients with Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL).

被引:0
|
作者
Giles, FJ
Vose, JM
Manshouri, T
Dey, A
Bociek, G
Bierman, PJ
Keating, M
Armitage, JO
Albitar, M
机构
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Nebraska, Med Ctr, Lincoln, NE 68583 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3346
引用
收藏
页码:805A / 805A
页数:1
相关论文
共 50 条
  • [1] Anticipation occurs in familial Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL).
    Wiernik, PH
    Wang, SQ
    Hu, XP
    Marino, P
    BLOOD, 1997, 90 (10) : 3964 - 3964
  • [2] INCIDENCE AND FACTORS INFLUENCING STEM CELL MOBILIZATION IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA (NHL) AND HODGKIN'S DISEASE (HD)
    Popat, U.
    Saliba, R.
    Ahlawat, S.
    Okoroji, G. J.
    Alousi, A.
    Anderlini, P.
    Andersson, B.
    de Lima, M.
    Jones, R.
    Kebriaei, P.
    Korbling, M.
    Nieto, Y.
    Qazilbash, M.
    Shpall, E. J.
    Khouri, I
    Giralt, S.
    Champlin, R.
    Hosing, C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 37 - 38
  • [3] Thymic residual masses in adult patients with Non-Hodgkin's Lymphoma (NHL) and Hodgkin's Disease (HD).
    Tartas, N
    Chacón, C
    Domenichini, E
    Pascuccelli, H
    Sporn, V
    Mazzucco, J
    Korin, J
    Barazzutti, L
    Ferro, H
    Busso, P
    Foncuberta, C
    Kusminsky, G
    Chacón, R
    Avalos, JS
    BLOOD, 1999, 94 (10) : 255B - 255B
  • [4] Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma
    Giles, FJ
    Vose, JM
    Do, KA
    Johnson, MM
    Manshouri, T
    Bociek, G
    Bierman, PJ
    O'Brien, SM
    Kantarjian, HM
    Armitage, JO
    Albitar, M
    LEUKEMIA RESEARCH, 2004, 28 (06) : 595 - 604
  • [5] ANGIOGENESIS IN INDOLENT NON-HODGKIN'S LYMPHOMA (NHL)
    Minoia, C.
    Zito, F. A.
    Quero, C.
    Rana, A.
    Lacobazzi, A.
    Lapietra, A.
    Giannoccaro, M.
    Daniele, G.
    Ferrucci, A.
    Guarini, A.
    CANCER TREATMENT REVIEWS, 2010, 36 : S117 - S118
  • [6] Angiogenesis in Indolent Non-Hodgkin's Lymphoma (NHL)
    Guarini, A.
    Minoia, C.
    Iacobazzi, A.
    Rana, A.
    Lapietra, A.
    Daniele, G.
    Ferrucci, A.
    Popescu, O.
    Labriola, A.
    Zito, F. A.
    ONCOLOGY, 2009, 77 : 148 - 148
  • [7] ANGIOGENESIS IN INDOLENT NON-HODGKIN'S LYMPHOMA (NHL)
    Guarini, A.
    Minoia, C.
    Iacobazzi, A.
    Rana, A.
    Lapietra, A.
    Giannoccaro, M.
    Ferrucci, A.
    Daniele, G.
    Vacca, A.
    Zito, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 610 - 611
  • [8] Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD)
    Coad, NAG
    Jones, TJ
    Muir, KR
    Parkes, SE
    Smith, K
    Raafat, F
    Mann, JR
    PEDIATRIC PATHOLOGY & LABORATORY MEDICINE, 1997, 17 (06): : 893 - 902
  • [9] Standardized uptake value (SUV) for staging of non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).
    Cortés-Blanco, A
    Martínez-Lázaro, R
    Zhuang, HM
    Alavi, AA
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 279P - 279P
  • [10] ASHAP salvage therapy for recurrent and refractory Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL).
    Hanel, M
    Hoffknecht, MM
    Peters, SO
    Fiedler, F
    Hanel, A
    Kruger, WH
    Zeller, W
    Braumann, D
    Illiger, HJ
    Metzner, B
    Schubert, JC
    Schmitz, N
    Weh, HJ
    Kroger, N
    Zander, AR
    BLOOD, 1997, 90 (10) : 4559 - 4559